Co-Diagnostics Seeks Approval for Reverse Split and $5.3M Warrant Exercise
CODX is trading near its 52-week low of $0.906 (10% above the low).
Summary
Co-Diagnostics seeks shareholder approval for a reverse stock split (up to 1-for-50) and the exercise of 3.4 million warrants that could raise $5.31 million, as the company fights to maintain its Nasdaq listing and fund operations amid a going concern warning.
Key Events · Corporate Governance and Compliance · CODX
-
Reverse Stock Split Proposed
Board seeks approval for a reverse split between 1-for-2 and 1-for-50, with final ratio and timing left to board discretion within 12 months. Primary purpose is maintaining Nasdaq listing compliance.
-
Warrant Exercise Could Raise $5.31M
3,404,724 new warrants at $1.56 per share would generate approximately $5.31 million in gross proceeds if fully exercised for cash. Warrants are not exercisable until shareholder approval is obtained.
-
Dilution Risk from Warrant Exercise
Full exercise would add 3,404,724 shares to the current 6,980,208 outstanding — a 48.8% increase in share count. Existing shareholders would see their ownership proportionally reduced.
-
Going Concern Backdrop
The company reported a going concern warning in its August 13 10-Q, with cash down to $3.6 million and a $15.4 million six-month net loss. The warrant proceeds are needed to fund operations.
Analysis · CODX · Industrial Applications And Services
Co-Diagnostics is asking shareholders to approve two survival measures: a reverse stock split of up to 1-for-50 to maintain its Nasdaq listing, and the exercise of 3.4 million warrants that would raise roughly $5.31 million in cash. The company has a going concern warning, only $3.6 million in cash as of its last 10-Q, and a $15.4 million six-month loss. The reverse split is designed to lift the stock price above Nasdaq's minimum bid requirement, while the warrant exercise provides critical operating capital. Both proposals carry dilution risk — the warrants alone would increase the share count by nearly 49% if fully exercised for cash.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $1.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2M. The 52-week trading range was $0.91 to $46.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.